Subscribe to Newsletter

Subspecialties

Subspecialties Other

Glaucoma awareness from a global perspective

| Richard Gallagher

To mark World Glaucoma Week, here are some of the many creative approaches being taken to communicate awareness of the disease around the world.

Subspecialties Glaucoma

Benchmarking Glaucoma

| Mark Hillen

What does analysis of the last five years of literature on glaucoma tell us about the priorities of the field and the major contributors to it?

Subspecialties Business and Innovation

CLASS-y Laser Treats Glaucoma

| Ehud Assia

Transforming complex, invasive and risky glaucoma surgery into a safe, elegant, and precise procedure.

Subspecialties Retina

Combining Laser and Anti-VEGF for the Treatment of DME

| Stela Vujosevic

Advances in understanding of the therapeutic mechanisms that underpin micropulse laser treatment suggest that protocols for treatment of diabetic macular edema should be integrated.

Subspecialties Glaucoma

All is Not Lost

| Mark Hillen

Vision training can restore some of the sight lost to glaucoma.

Subspecialties Basic & Translational Research

STAP! Not so fast

| Mark Hillen

The new method to produce stem cells has run into difficulties in the form of image irregularities and the failure of other labs to reproduce the findings.

Subspecialties Retina

Aspirin not Linked to AMD

| Mark Hillen

Previous studies linked aspirin use with age-related macular degeneration, but new data suggest otherwise: aspirin is innocent of all charges.

Subspecialties Retina

Statins Protect Elderly Against Macular Degeneration

| Mark Hillen

If you’re aged over 68 years, then statins significantly reduce your risk of developing AMD; it has no impact on younger age groups.

Subspecialties Cornea / Ocular Surface

Dua for the Price of One

| Mark Hillen

The finding that the core of the trabecular meshwork is an extension of Dua’s layer may have significance in understanding and treating glaucoma.

Subspecialties Retina

Inkjet Interventions

| Mark Hillen

Can you envisage a future in which deploying a tiny cell-spraying device during vitreoretinal surgery reverses years of retinal cell death? Keith Martin can.

Register to The Ophthalmologist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Ophthalmologist magazine

Register

Disclaimer

The Ophthalmologist website is intended solely for the eyes of healthcare professionals. Please confirm below: